| Literature DB >> 30573520 |
Jian Zhang1,2, Ying-Qin Li1, Rui Guo1, Ya-Qin Wang1, Pan-Pan Zhang1, Xin-Ran Tang1, Xin Wen1, Xiao-Hong Hong1, Yuan Lei1, Qing-Mei He1, Xiao-Jing Yang1, Ying Sun1, Jun Ma3, Na Liu3.
Abstract
Altered DNA methylation is a key feature of cancer, and aberrant methylation is important in nasopharyngeal carcinoma (NPC) development. However, the methylation mechanisms underlying metastasis of NPC remain unclear. Analyzing data from public databases and conducting our own experiments, we report here that promoter hypermethylation of SHISA3 is common and contributes to the downregulation of this gene in many types of tumors, including NPC. SHISA3 suppressed NPC cell invasion and metastasis in vitro and in vivo by impeding the E3 ubiquitin ligase tripartite motif containing 21 (TRIM21)-mediated ubiquitination and degradation small G protein signaling modulator 1 (SGSM1) and by inhibiting the MAPK pathway activation. Silencing SGSM1 abrogated the inhibitory effect of SHISA3 on NPC cell migration and invasion. This newly identified SHISA3-TRIM21-SGSM1 axis could be a novel therapeutic target in NPC. SIGNIFICANCE: These findings highlight the mechanism by which a newly identified tumor suppressor SHISA3 suppresses invasion and metastasis of nasopharyngeal carcinoma. ©2018 American Association for Cancer Research.Entities:
Year: 2018 PMID: 30573520 DOI: 10.1158/0008-5472.CAN-18-1754
Source DB: PubMed Journal: Cancer Res ISSN: 0008-5472 Impact factor: 12.701